Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.

Rooney T, Edwards CK 3rd, Gogarty M, Greenan L, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B.

Rheumatol Int. 2010 Nov;30(12):1571-80. doi: 10.1007/s00296-009-1191-1. Epub 2009 Oct 22.

PMID:
19847430
2.

Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome.

Haynes D, Crotti T, Weedon H, Slavotinek J, Au V, Coleman M, Roberts-Thomson PJ, Ahern M, Smith MD.

Arthritis Rheum. 2008 Jul 15;59(7):911-20. doi: 10.1002/art.23818.

3.

Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade.

Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B.

Ann Rheum Dis. 2010 Apr;69(4):706-14. doi: 10.1136/ard.2009.108324. Epub 2009 May 20.

PMID:
19460761
4.

Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.

Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.

Arthritis Rheum. 2006 Jan;54(1):76-81.

5.

Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis.

Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP.

Ann Rheum Dis. 2012 Jan;71(1):108-13. doi: 10.1136/annrheumdis-2011-200198. Epub 2011 Nov 8.

PMID:
22072013
6.

The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.

Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D.

Arthritis Rheum. 2008 Mar;58(3):718-29. doi: 10.1002/art.23290.

7.

Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.

Haynes DR, Barg E, Crotti TN, Holding C, Weedon H, Atkins GJ, Zannetino A, Ahern MJ, Coleman M, Roberts-Thomson PJ, Kraan M, Tak PP, Smith MD.

Rheumatology (Oxford). 2003 Jan;42(1):123-34.

PMID:
12509625
8.

Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.

Arthritis Rheum. 2004 Jan;50(1):277-90.

9.

Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.

Syversen SW, Goll GL, van der Heijde D, Landewé R, Gaarder PI, Odegård S, Haavardsholm EA, Kvien TK.

J Rheumatol. 2009 Feb;36(2):266-72. doi: 10.3899/jrheum.080180.

PMID:
19132792
10.

Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis.

Crotti TN, Ahern MJ, Lange K, Weedon H, Coleman M, Roberts-Thomson PJ, Haynes DR, Smith MD.

J Rheumatol. 2003 Nov;30(11):2319-24.

PMID:
14677171
11.

Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.

Lanfant-Weybel K, Michot C, Daveau R, Milliez PY, Auquit-Auckbur I, Fardellone P, Brazier M, Mejjad O, Daragon A, Krzanowska K, Jouen F, Tron F, Le Loarer F, Le Loët X, Vittecoq O.

Joint Bone Spine. 2012 Dec;79(6):574-80. doi: 10.1016/j.jbspin.2011.11.006. Epub 2012 Mar 27.

PMID:
22459417
12.

RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.

Melchiorre D, Milia AF, Linari S, Romano E, Benelli G, Manetti M, Guiducci S, Ceccarelli C, Innocenti M, Carulli C, Civinini R, Morfini M, Matucci-Cerinic M, Ibba-Manneschi L.

J Rheumatol. 2012 Aug;39(8):1678-86. doi: 10.3899/jrheum.120370. Epub 2012 Jul 1.

PMID:
22753650
13.

Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.

Catrina AI, Klareskog L.

Arthritis Rheum. 2008 Nov 15;59(11):1685; author reply 1685-6. doi: 10.1002/art.24210. No abstract available.

14.

Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.

Smith MD, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ.

Rheumatology (Oxford). 2001 Sep;40(9):965-77.

PMID:
11561106
15.

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.

Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M.

Arthritis Rheum. 2006 Jun;54(6):1772-7.

16.
17.

Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.

Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT.

Arthritis Rheum. 2008 Aug;58(8):2397-408. doi: 10.1002/art.23653.

18.

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.

Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.

Rheumatology (Oxford). 2006 Sep;45(9):1068-76. Epub 2006 Feb 20.

PMID:
16490750
19.

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.

Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J, He D.

BMC Complement Altern Med. 2015 Mar 24;15:77. doi: 10.1186/s12906-015-0566-y.

20.

IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.

Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.

Mod Rheumatol. 2015 Mar;25(2):270-7. doi: 10.3109/14397595.2014.950035. Epub 2014 Aug 27.

PMID:
25159156

Supplemental Content

Support Center